Literature DB >> 18261391

[Definition and current situation of cardiometabolic risk].

P Conthe, J M Lobos.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18261391     DOI： 10.1157/13115200

Source DB:  PubMed          Journal:  Rev Clin Esp        ISSN： 0014-2565            Impact factor:   1.556


× No keyword cloud information.
  4 in total

Review 1.  Dietary Advanced Glycation End Products and Cardiometabolic Risk.

Authors:  Claudia Luévano-Contreras; Armando Gómez-Ojeda; Maciste Habacuc Macías-Cervantes; Ma Eugenia Garay-Sevilla
Journal:  Curr Diab Rep       Date:  2017-08       Impact factor: 4.810

2.  [Prostate cancer, antiandrogen treatment and cardiovascular risk].

Authors:  Santiago Reinoso Hermida; Gabriel J Díaz Grávalos; Aida Robles Castiñeiras; Clara Villar Latorre; Ana López González; Antonio Ojea Calvo
Journal:  Aten Primaria       Date:  2011-01-05       Impact factor: 1.137

3.  Metabolic syndrome and associated risk factors.

Authors:  Ajeet Singh Bhadoria
Journal:  J Family Community Med       Date:  2015 Jan-Apr

4.  Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study.

Authors:  Maria Angeles Via-Sosa; Cristina Toro; Pere Travé; Marian A March
Journal:  BMC Public Health       Date:  2014-05-22       Impact factor: 3.295
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.